Pharma firm settles probe for allegedly paying off competition

Endo International, the pharmaceutical company that makes Lidoderm, on Monday settled a regulatory probe into allegations it paid the maker of a rival drug to keep the lower-priced generic off store shelves. The $250 million in payments to Watson Laboratories allowed Endo to jack up the price of its lidocaine patches. Between 2008 and 2013,...